Aerobic
and anaerobic bacteria are widely involved in the occurrence of human
infections. Recent scientific innovations, particularly in anaerobic and aerobic
bacteriology and susceptibility testing have been instrumental in refining
processes as well as the technical elements used in transporting specimens,
growing, evaluating, and identifying bacteria, and performing susceptibility
tests. Because of the major significance of both anaerobic and aerobic bacteria
in identifying antimicrobial susceptibility patterns, it’s become quite
increasingly critical to use anaerobic and aerobic bacteriology and
susceptibility testing methods to identify organisms and recognize
susceptibilities.
Today,
there is quite an abundance of commercially available, pre-reduced, and
sterilized aerobic bacteriology and susceptibility testing systems in the
market, and they have been extremely helpful in both bacterial identification
and recognition of bacterial or antimicrobial susceptibility. Also recently,
there have been major developments in the production of rapid identification
systems, which are designed based on multiple testing on pre-formed enzymes.
There have been major advances in this area of study and there is a high chance
of such systems becoming commercially available in the near future.
There
are also great strides in both microdilution anaerobic and aerobic
bacteriology and susceptibility testing systems, which continue to make routine testing for bacterial
identification and susceptibility testing possible. Antibiotic susceptibilities
must only be performed where and when appropriate. In these instances,
organisms are typically evaluated according to their clinical significance.
When appropriate, both the genus and species are determined and testing for
susceptibility is performed.
The
susceptibility of specific organisms to particular microbial agents can be used
to identify or gauge the relative success rate or failure that could be
expected if a certain agent is to be used as a treatment for that organism.
Susceptibility testing reports and analyses can be used as a guide to confirm
empiric therapeutic decisions or a guide for the right choice of therapy as well
as to confirm the organism’s antimicrobial resistance.
